VNOV — Vitanova Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapHigh Flyer

Annual balance sheet for Vitanova Life Sciences, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2022 April 30th	2023 April 30th	2024 April 30th	2025 April 30th	2026 April 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.023	0.009	0.593	0.783	1.6
Net Total Accounts Receivable
Net Total Receivables	—	—	0.461	1.43	0.727
Total Inventory
Total Other Current Assets
Total Current Assets	0.023	0.009	1.19	2.26	2.43
Other Long Term Assets
Total Assets	0.023	0.009	1.19	2.26	2.45
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.058	0.068	0.137	0.348	0.396
Total Long Term Debt
Total Debt
Total Liabilities	0.058	0.068	0.137	0.348	0.396
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.035	-0.059	1.06	1.91	2.05
Total Liabilities & Shareholders' Equity	0.023	0.009	1.19	2.26	2.45
Total Common Shares Outstanding